-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster II

Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2019: 6:00 PM-8:00 PM
Hall B, Level 2 (Orange County Convention Center)

Ing S Tiong, MBChB, FRACP, FRCPA1,2, Richard Dillon, MA, PhD, MRCP, FRCPath3,4, Adam Ivey, BSc, MSc, PhD1*, Tse-Chieh Teh, MBBS, PhD, FRACP, FRCPA1*, Catherine Vassili, RN, MN1*, Vanessa Roma Donati, RN2*, David Taussig, PhD, MRCP, FRCPath5, Nicola Potter, PhD6*, Jelena Jovanovic, PhD6*, Anju Kanda, MSc6*, Manohursingh Runglall, MSc6*, Nicola Foot, MSc7*, Mikel Valganon, PhD7*, Nigel H. Russell, MD8, Kavita Raj, MD, PhD9,10, Anthony P Schwarer, MD, MBBS (Hons), FRACP, FRCPA11, Chun Yew Fong, MBBS, PhD, FRACP, FRCPA2, Andrew Grigg2*, Steven Knapper, DM12 and Andrew H. Wei, MBBS, PhD13

1The Alfred Hospital and Monash University, Melbourne, Australia
2Department of Clinical Haematology, Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia
3Department of Medical and Molecular Genetics, King's College, London, ENG, United Kingdom
4St. Thomas' Hospital, London, United Kingdom
5Haematology, Royal Marsden Hospital, London, United Kingdom
6Cancer Genetics Laboratory, King's College, London, United Kingdom
7Molecular Oncology Diagnostic Unit, Guy’s Hospital, London, United Kingdom
8Nottingham University Hospital, Nottingham, United Kingdom
9Guys and St Thomas' NHS Foundation Trust, London, United Kingdom
10UCL Hospital NHS foundation Trust, London, United Kingdom
11Box Hill Hospital, Melbourne, Australia
12Department of Haematology, University of Wales, Cardiff, United Kingdom
13The Alfred Hospital and Monash University, Melbourne, VIC, Australia

Seth E Karol, MD1, Todd M Cooper, DO2, Henrique Bittencourt3, Lia Gore, MD4, Maureen M O'Brien, MD5, Christopher Fraser, MD6, Marion Gambart, MD7*, Gunnar Cario, MD, PhD8*, Christian Michel Zwaan, MD, PhD9,10, Jean-Pierre Bourquin, MD, PhD11, Mignon L. Loh, MD12, Hubert Caron, MD, PhD13*, Betty Prine14*, Ahmed Hamed Salem, PhD, FCP14, Kristina Unnebrink15*, Bo Tong, PhD14*, Tammy Palenski, PhD14 and Andrew E. Place, MD, PhD16

1Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
2Division of Hematology and Oncology, Seattle Children's Hospital, Seattle, WA
3Clinical Pharmacology Unit, CHU Sainte-Justine, Montreal, QC, Canada
4Peds Heme/Onc/BMT-CT, University of Colorado, Children's Hospital Colorado, Aurora, CO
5Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
6Queensland Children's Hospital, South Brisbane, QLD, Australia
7CHU de Toulouse, Toulouse, France
8Pediatrics, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
9Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
10Department of Pediatric Oncology/Hematology, Erasmus University Medical Center-Sophia Children’s Hospital, Rotterdam, Netherlands
11Universitaets-Kinderspital Zurich, Zurich, Switzerland
12University of California San Francisco, UCSF Benioff Children’s Hospital and the Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
13F. Hoffman-La Roche Ltd., Basel, Switzerland
14AbbVie Inc., North Chicago, IL
15AbbVie Deutschland GmbH & Co. KG, Ludwigshafen, Germany
16Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA

Daniel J. DeAngelo, MD, PhD1, Harry P. Erba, MD, PhD2, Brian A Jonas, MD, PhD3, Michael E O'Dwyer, MD4, Paula Marlton, MBBS (Hons), FRACP, FRCPA5, Gerwin Huls, MD, PhD6*, Jane L. Liesveld, MD7, Brenda Cooper, MD8, Bhavana Bhatnagar, DO9, Geoffrey L. Uy, MD10, Gavin Cull, MB, BS, FRACP, FRCPA 11, Michael B. Armstrong, MD, PhD12, William E. Fogler, PhD13, Mary M Chen, MD, PhD14, John L. Magnani, PhD15, Helen M Thackray, MD14, Eric J. Feldman, MD14, Anjali S. Advani, MD16 and Pamela S. Becker, MD, PhD17,18,19

1Dana-Farber Cancer Institute, Boston, MA
2Division of Hematologic Malignancy and Cell Therapy, Duke University, Durham
3UC Davis Comprehensive Cancer Center, Sacramento, CA
4National University of Ireland Galway, Galway City, Ireland
5Princess Alexandra Hospital, University of Queensland School of Medicine, Brisbane, Australia
6Hematology, University Medical Center Groningen, Groningen, Netherlands
7Wilmot Cancer Institute, University of Rochester, Rochester, NY
8Seidman Cancer Center, University Hospitals, Cleveland, OH
9Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
10Division of Oncology, Washington University School of Medicine, Saint Louis, MO
11Department of Haematology, Sir Charles Gairdner Hospital Hematology Care Centre, Nedlands, WEA, Australia
12IQVIA Biotech, Morrisville, NC
13Glycomimetics, Inc., Rockville, MD
14GlycoMimetics Inc., Rockville, MD
15GlycoMimetics, Inc., Rockville, MD
16Hematologic Oncology and Blood Disorders, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
17Division of Hematology, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
18University of Washington Inst. for Stem Cell and Regenerative Med., Seattle, WA
19Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Gautam M. Borthakur, MD1, William B. Donnellan, MD2,3, Scott R. Solomon, MD4, Camille Abboud, MD5, Aziz Nazha, MD6, Milena Mazan, PhD7*, Michal Mikula, MD, PhD8*, Eliza Majewska, PhD7*, Katarzyna Wiklik, PhD7*, Aniela Golas, PhD7*, Marcus Järås, PhD9, Marion Chapellier, PhD9*, Anna Polak, PhD10*, Arkadiusz Bialas, PhD7*, Renata Windak, PhD7*, Jerzy Ostrowski, Prof., MD, PhD8,11*, Przemyslaw Juszczynski, Prof., MD, PhD10*, Pawel Chrom, MD, PhD7*, Tomasz Rzymski, PhD7* and Krzysztof Brzózka, PhD7

1University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
2Tennessee Oncology, PLLC, Nashville, TN
3Sarah Cannon Research Institute, Nashville, TN
4Leukemia Program, Northside Hospital Cancer Center Institute, Atlanta, GA
5Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
6Leukemia Program, Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Avon Lake, OH
7Selvita S.A., Kraków, Poland
8Department of Genetics, Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warszawa, Poland
9Department of Laboratory Medicine, Division of Clinical Genetics, Lund University, Lund, Sweden
10Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warszawa, Poland
11Department of Gastroenterology, Hepatology and Clinical Oncology, Medical Center for Postgraduate Education, Warszawa, Poland

Guillermo Garcia-Manero, MD1, Maciej Kaźmierczak2*, Chun Yew Fong, MBBS, PhD, FRACP, FRCPA3, Pau Montesinos, MD, PhD4*, Adriano Venditti5, Silvia Mappa, MD6*, Riccardo Spezia7* and Lionel Ades, MD, PhD8

1University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX
2Department of Hematology, Poznań University of Medical Sciences, Poznań, Poland
3Department of Clinical Haematology, Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia
4Hospital Universitari i Politècnic La Fe, Valenica, Spain
5Fondazione Policlinico Tor Vergata, Rome, Italy
6Clinical Research and Development, Helsinn Healthcare SA, Lugano, Switzerland
7Statistics and Data Management, Helsinn Healthcare, Lugano, Switzerland
8Institut Univeristaire d'Hematologie, Hopital Saint Louis, Paris, France

Eleanor Minogue, BSc1*, David Millar, BSc, PhD1*, Yan Chuan, PhD1*, Songfa Zhang, MD PhD1*, Korneel Grauwet, PhD1*, Mei Guo1*, Adam Langenbucher1*, Cyril H Benes2*, James Heather, PhD1*, Jeremy Minshull, PhD3*, Michael S. Lawrence, PhD4*, Rupa Narayan1*, David M. Langenau, PhD5*, Timothy A. Graubert, MD6 and Mark Cobbold7*

1Massachusetts General Hospital, Boston, MA
2Massachusetts General Hospital, Boston
3Atum Biotechnology, Newark, CA
4Massachusetts General Hospital Cancer Center and Department of Pathology, Harvard Medical School, Charlestown, MA
5Massachusetts General Hospital, Charlestown, MA
6Massachussets General Hospital, Charlestown, MA
7MGH, Boston, MA

Ting Liu, MD1, Huanling Zhu, M.D.1*, Xuekun Yao, M.M.2*, Yueying Peng, M.M.2*, Yumei Wang, M.E.3*, Guoning Zhan, B.E.4*, Jing Yuan, M.S.5*, Shaonan Ni, M.M.5*, Jie Qiao, Ph.D.6*, Zijian Hu, M.D.6* and Cheng Lyu, D.Eng.6*

1Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
2Department of Medicine, Clinical Development Division, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Shijiazhuang, China
3Department of Registration & Bioequivalence, R&D Division, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Shijiazhuang, China
4Department of Clinical Operations, Clinical Development Division, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Shijiazhuang, China
5Department of Biostatistics, Clinical Development Division, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Shijiazhuang, China
6Department of Translational Medicine, Clinical Development Division, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Shanghai, China

Kamal Menghrajani, MD1, Sheng F Cai, MD, PhD2, Sean M. Devlin, PhD3*, Scott A. Armstrong, MD, PhD4, Richard Piekarz, MD, PhD, MS, BA5*, Michelle Rudek, PharmD, PhD6*, Martin S. Tallman, MD7 and Eytan M. Stein, MD1

1Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Center for Epigenetic Research, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Pediatric Oncology, Dana-Faber Cancer Institute, Boston, MA
5Cancer Therapy Evaluation Program, National Cancer Institute, National Institutes of Health, Bethesda, MD
6Johns Hopkins University, Baltimore, MD
7Memorial Sloan Kettering Cancer Center, New York, NY

Justin M. Watts, MD1, Terrence J Bradley, MD1, Amber Thomassen2*, Andrew M. Brunner, MD3, Mark D. Minden, MD, PhD4, Nikolaos Papadantonakis, MD, PhD, MSc5, Sameem Abedin, MD6,7, Amanda J Baines8*, Olena Barbash, PhD9*, Shelby Gorman9*, Brandon E Kremer, MD/PhD9 and Gautam M. Borthakur, MD10

1University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
2Sylvester Cancer Center, University of Miami, Miami, FL
3Dana-Farber Cancer Institute, Boston, MA
4Leukemia Program, Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
5Taussig Cancer Institute, Birmingham, AL
6McGaw Medical Center At Northwestern Memorial Hospital, Milwaukee, WI
7Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
8GlaxoSmithKline, Stevenage, United Kingdom
9GlaxoSmithKline, Collegeville, PA
10University of Texas MD Anderson Cancer Center, Department of Leukemia, Houston, TX

Ingrid G Winkler, PhD1, Valerie Barbier, Masters2*, Joshua Tay, PhD1*, Jean-Pierre Levesque, PhD2, John L. Magnani, PhD3, Corrine E Fiveash, BSc(Hons)2* and Johanna D Erbani2*

1Mater Research Institute - University of Queensland, Brisbane, QLD, Australia
2Mater Research Institute - University of Queensland, Brisbane, Australia
3GlycoMimetics, Inc., Rockville, MD

Timothy S. Pardee, MD, PhD1, Sanjeev Luther, MBA2*, Marc E. Buyse, ScD3*, Bayard L Powell, MD4 and Jorge E. Cortes, MD5

1Rafael Pharmaceuticals, Newark, NJ
2Rafael Pharmaceuticals, CRANBURY, NJ
3IDDI, Louvain-la-Neuve, BEL
4Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, NC
5Georgia Cancer Center, Augusta University, Augusta

Tianyu Cai, PhD1*, Kathryn L Black, PhD2*, Ammar S. Naqvi, PhD2*, Deanne Taylor, PhD2*, Ming Zhao, MD3*, Qi Yuan4*, Mayumi Sugita, MD5, Roman Galetto, PhD6*, Agnès Gouble, PhD6*, Julianne N. P. Smith, PhD7, Antonio Cavazos1*, Lina Han, PhD1, Qi Zhang, PhD1*, Vinitha Mary Kuruvilla, MSc1*, Helen Ma, MS1*, Sergej Konoplev8*, Guilin Tang, MD8*, Jun Gu, MD, PhD3*, Xiaoping Su, PhD4*, Sattva S Neelapu, MD9, Andrew A. Lane, MD, PhD10, Hagop M. Kantarjian, MD1, Monica L. Guzman, PhD5, Naveen Pemmaraju, MD1, Andrei Thomas-Tikhonenko, PhD2 and Marina Y Konopleva, MD, PhD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
3School of Health Professions, The University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX
5Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY
6Cellectis SA, Paris, France
7Cellectis Inc., New York, NY
8Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Tim Chan, PhD1*, Xiaohong Ma1*, Fernando Carvajal-Borda, DVM1*, Jose Velez1*, Jacques Plummer1*, Lindsey Shepard1*, Rutul R Shah1*, David A Sallman, MD2,3 and Helen Sabzevari, PhD1*

1Precigen, Inc, Germantown, MD
2H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Xiaofei He, B.S.1*, Caleb Hawkins, B.S.1*, Lauren Lawley, B.S.1*, Mark Wunderlich, MS2*, Benjamin Mizukawa, MD3,4, Xiang-ming Zha, Ph.D.5*, Stephanie Halene, MD 6 and Jing Fang, MD, PhD7

1Drug Discovery and Biomedical Sciences, University of South Carolina College of Pharmacy, Columbia, SC
2Experimental Hematology and Cancer Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
3Oncology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
4Department of Pediatrics, University of Cincinnati, Cincinnati, OH
5Department of Physiology and Cell Biology, University of South Alabama College of Medicine, Mobile, AL
6Yale Univ. School of Medicine, New Haven, CT
7University of South Carolina College of Pharmacy, Columbia, SC

Andrew H. Wei, MBBS, PhD1, Chun Yew Fong, MBBS, PhD, FRACP, FRCPA2, Pau Montesinos, MD, PhD3*, Maria Calbacho, MD4*, Jordi Sierra Gil, MD, PhD5*, Jaime Perez De Oteyza, MD, PhD6, Jacob M. Rowe, MB, BS7, Ofir Wolach, MD8*, Yishai Ofran, MD9, Yakir Moshe, MD10*, Jichao Sun, PhD11*, Jan Baughman, MPH12*, Eileen McNulty, MS11*, Ezio Bonvini, MD11, Jon M. Wigginton, MD11* and Jan K Davidson-Moncada, MD, PhD13

1The Alfred Hospital, Melbourne, VIC, Australia
2Department of Clinical Haematology, Austin Health and Olivia Newton John Cancer Research Institute, Melbourne, Australia
3Hospital Universitari i Politècnic La Fe, Valenica, Spain
4Hematology and Hemotherapy, Hospital 12 de Octubre, Madrid, Spain
5Hematologia Clínica, Hospital de la Santa Creu i de Sant Pau, Barcelona, Spain
6Hospital Universitario Sanchinarro, Madrid, Spain
7The Ruth and Bruce Rappaport Faculty of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel
8Rabin Medical Center, Petah Tikva, Israel
9Rambam Medical Center, Haifa, Israel
10Sackler faculty of Medicine, Tel Aviv University, Department of Hematology, Tel Aviv (Sourasky) Medical Center, Tel Aviv, Israel
11MacroGenics, Inc., Rockville, MD
12MacroGenics, Inc., South San Francisco, CA
13MacroGenics, Inc., Washington, DC

Satoshi Kitazawa, PhD1*, Yukiko Ishii, PhD1*, Keiko Makita-Suzuki1*, Koichi Saito, PhD1*, Kensuke Takayanagi1*, Hiromi Sugihara1*, Shun Matsuda, PhD2*, Takayuki Yamakawa, PhD1*, Yasuhiro Tsutsui1*, Tadashi Tanaka1*, Tomohisa Hatta, PhD3*, Tohru Natsume, PhD3*, Toru Kondo, PhD4*, Yuichi Ishikawa, MD, PhD5, Shinji Hagiwara, PhD1* and Hitoshi Kiyoi, MD, PhD5

1Bio Science & Engineering Laboratory, FUJIFILM Corporation, Kaisei, Japan
2Analysis Technology Center, FUJIFILM Corporation, Minami-ashigara, Japan
3Molecular Profiling Research Center for Drug Discovery, The National Institute of Advanced Industrial Science and Technology, Tokyo, Japan
4Division of Stem Cell Biology, Institute for Genetic Medicine, Hokkaido University, Sapporo, Japan
5Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan

Neil Beeharry1*, Sean Landrette, PhD1*, Jeff Grotzke, PhD1*, Sophia Gayle, PhD1*, Marylens Hernandez, PhD1*, Stephanie Halene, MD 2, Peter R Young, PhD1*, Langdon L Miller, MD1, Tian Xu, PhD1*, Jonathan Rothberg, PhD1* and Henri Lichenstein, PhD1*

1AI Therapeutics, Guilford, CT
2Yale Univ. School of Medicine, New Haven, CT

Maria Caterina Rotiroti, PhD1*, Chiara Buracchi, PhD1*, Silvia Arcangeli, PhD1*, Chiara F Magnani2*, Claudia Cappuzzello, PhD1*, Zsuzsanna Izsvak, PhD3*, Stefania Galimberti, PhD4*, Maria Grazia Valsecchi, PhD4*, Giuseppe Dastoli, MD1*, Marta Serafini, PhD1*, Ettore Biagi, MD1*, Andrea Biondi, MD1 and Sarah Tettamanti, PhD1*

1Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicocca/Fondazione MBBM, Monza, Italy
2Tettamanti Research Center, Department of Pediatrics, University of Milano-Bicoc, Monza, Italy
3MDC-Berlin, Berlin, Germany
4Center of Biostatistics for Clinical Epidemiology, School of Medicine and Surgery, University of Milan-Bicocca, Monza, Italy

Mark Sellin1*, Ryan Mack1*, Matthew C. Rhodes2*, Lei Zhang, PhD1*, Wei Wei1*, Peter Breslin, PhD1*, Stephanie Berg, DO1, Suming Huang, PhD3, Richard Taylor, PhD2* and Jiwang Zhang, MD4

1Department of Cancer Biology, Cardinal Bernardin Cancer Center, Loyola University Medical Center, Maywood, IL
2The Warren Family Research Center for Drug Discovery and Development and the Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN
3Department of Pediatrics, Division of Hematology and Oncology, Penn State Cancer Institute, Pennsylvania State University Hershey College of Medicine, Hershey, PA
4Department of Cancer Biology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, IL

Alejandra Leivas, PhD, BS, MSc1,2*, Laura Córdoba, MSc3,4*, Antonio Valeri, PhD5,6*, Paula Rio, PhD7*, Daniel Primo, PhD8*, Joan Ballesteros, PhD9, Lucía Fernández, PhD4*, Antonio Perez-Martinez, MD, PhD10*, Dean Anthony Lee, MD, PhD11, Daniel J. Powell Jr., PhD12* and Joaquin Martinez-Lopez, MD, PhD13,14*

1H12O-CNIO Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain
2Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
3Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
4H12O-CNIO Hematological Malignancies Clinical Research Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain
5Hospital 12 De Octubre, Madrid, ESP
6H12O-CNIO hematological Malignancies Clinical Research Unit, Spanish National Cancer Research Center (CNIO), Madrid, Spain
7Hematopoietic Innovative Therapies Division, CIEMAT/CIBERER/IIS. Fundación Jiménez Díaz, Madrid, Spain
8Parque Científico de Madrid, Vivia Biotech, Madrid, Spain
9Vivia Biotech, Madrid, Spain
10Department of Pediatrics, Hospital Universitario La Paz, Madrid, Spain
11Hem/Onc/BMT, The Research Institute At Nationwide Children’s Hospital, Columbus, OH
12Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA
13Hematology, Hospital Universitario 12 De Octubre, Madrid, ESP
14H12O-CNIO Hematological Malignancies Clinical Research Unit, Spanish National Cancer Research Center, Madrid, Spain

Jimin Shi, MD1,2,3*, Liqin Cao, MD1,2,3*, Yi Luo, MD1,2,3*, Yanmin Zhao, MD1,2,3*, Yamin Tan, MD1,2,3*, Jian Yu, MD1,2,3*, Xiaoyu Lai, MD1,2,3*, Yuanyuan Zhu, MD1,2,3*, Yongxian Hu, MD1,2,3*, Jingsong He, MD1,2,3*, Jie Sun, MD1,2,3*, Weiyan Zheng, MD1,2,3*, Guoqing Wei, MD1,2,3* and He Huang1,2,3

1Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
2Zhejiang Engineering Laboratory for Stem Cell and Immunotherapy, Hangzhou, China
3Institute of Hematology, Zhejiang University, Hangzhou, China

Nunki Hassan*, Basit Salik*, Alastair Duly, PhD* and Jenny Yingzi Wang, PhD

Children's Cancer Institute, Randwick, NSW, Australia

Malathi Kandarpa, PhD1*, Luke F. Peterson, PhD2*, Harish Potu, PhD2*, Megha Ramappan2*, Yihong Liu2*, Avery Polk3*, Shaomeng Wang, PhD3* and Moshe Talpaz, MD 2

1Rogel Cancer Center, University of Michigan, Ann Arbor, MI
2Rogel Cancer Center, The University of Michigan, Ann Arbor, MI
3University of Michigan, Ann Arbor, MI

Justine Decroocq, MD1, Rudy Birsen, MD2*, Jordi Mano, MSc1*, Guillemette Fouquet3*, Mathilde Gotanègre, MSc4*, Laury Poulain, PhD5*, Sarah Mouche6*, Anne-Sophie Alary1*, Adrien Grenier, MD, PhD7*, Fetta Mazed, PhD1*, Johanna Mondesir, MD7, Nicolas Chapuis, PharmD, PhD8,9,10*, Aicha Boughalem, MD11*, Marc Le Lorc’h11*, Ivan C Moura, PhD12, Olivier Hermine, MD, PhD13,14*, Isabelle Radford-Weiss15*, Jean-Emmanuel Sarry, PhD16*, Eric Pasmant, MD, PhD1*, Olivier Kosmider, PharmD, PhD17*, Didier Bouscary, MD, PhD18* and Jerome Tamburini, MD, PhD6,7*

1Institut Cochin, Département Développement, Reproduction, Cancer, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 8104, Institut National de la Santé et de la Recherche Médicale (INSERM) U1016, paris, France
2Cochin Hospital, Hematology Department, Paris, France
3Institut Imagine, Inserm U1163, Paris, France
4Cancer Research Center of Toulouse, Unité Mixtes de Recherche 1037 INSERM, Toulouse, France
5Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, 1211, Geneva 4, Switzerland., Geneva, Switzerland
6Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland
7Institut Cochin, Département Développement, Reproduction, Cancer, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 8104, Institut National de la Santé et de la Recherche Médicale (INSERM) U1016, Paris, France
8Service d'Hématologie Biologique, Hopital Cochin APHP Paris, Paris, France
9INSERM U1016, Paris Descartes University, Paris, France
10Assistance Publique Hôpitaux de Paris, Laboratoire d'hématologie, Hôpital Cochin, Institut Cochin, INSERM U1016, University Paris Descartes, Paris, France
11cytogenetics, Necker Enfants malades hospital, paris, France
12imagine institut, INSERM U 1163 / CNRS ERL 8254, PARIS, France
13Hematology Department, AP-HP Hôpital Necker, University Paris Descartes, Paris, France
14Hematology Department / Hemophilia Center, Necker University Hospital, AP-HP, Paris, France
15Hôpital Necker-Enfants malades, AP-HP, Paris, France
16CRCT/Inserm, Toulouse, France
17Assistance Publique Hôpitaux de Paris, Laboratoire d'hématologie, Hôpital Cochin, APHP Laboratoire d'Hématologie, Hôpital Cochin, Paris, France
18Paris Descartes University, Sorbonne Paris Cité, Paris, France

Yuichi Ishikawa, MD, PhD1, Koichi Saito, PhD2*, Naomi Kawashima, MD, PhD1*, Michie Morimoto2*, Hidetoshi Murao, PhD2*, Daisuke Terada3*, Takeshi Yamaura2*, Shinji Hagiwara, PhD2* and Hitoshi Kiyoi, MD, PhD1

1Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
2Bio Science & Engineering Laboratory, FUJIFILM Corporation, Kaisei, Japan
3Analysis Technology Center, FUJIFILM Corporation, Minamiashigara, Japan

Jessica Liegel, MD1, Dina Stroopinsky, PhD1*, Haider Ghiasuddin1*, Adam Morin1*, Marzia Capelletti, PhD, MMSc1*, Shira Orr, PhD1*, Maryam Rahimian, MD1*, Lina Bisharat1*, Shufen Meng, MD1*, Myrna Nahas, MD2, Matthew Weinstock, MD1, Donald Kufe, MD3*, Jacalyn Rosenblatt, MD1 and David E. Avigan, MD4

1Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
2Beth Israel Deaconess Medical Center, Harvard Medical School, Brookline, MA
3Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
4Beth Israel Deaconess Medical Center, Boston, MA

Tomasz Zal, PhD1*, Mateusz Rytelewski, PhD1*, Rodrigo Jacamo, PhD2*, Malgorzata Anna Zal, MSc3*, Meenakshi Shanmugasundaram1* and Michael Andreeff, MD, PhD 4

1Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX
2Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
4Section of Molecular Hematology and Therapy, Department of Leukemia, MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH